![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 12, 8650-8656, March 24, 2000
From the Although numerous studies document
caspase-independent ceramide generation preceding apoptosis upon
environmental stress, the molecular ordering of ceramide
generation during cytokine-induced apoptosis remains uncertain. Here,
we show that CD95-induced ceramide elevation occurs during
the initiation phase of apoptosis. We titrated down the amount of FADD
transfected into HeLa and 293T cells until it was insufficient for
apoptosis, although cycloheximide (CHX) still triggered the effector
phase. Even in the absence of CHX, ceramide levels increased rapidly,
peaking at 2.7 ± 0.2-fold of control 8 h post-transfection.
Dominant negative FADD failed to confer ceramide generation or
CHX-mediated apoptosis. Ceramide generation induced by FADD was
initiator caspase-dependent, being blocked by crmA. Limited
pro-caspase 8 overexpression also increased ceramide levels 2.7 ± 0.2-fold, yet failed, without CHX, to initiate apoptosis. Expression of
membrane-targeted oligomerized CD-8 caspase 8 induced apoptosis without
CHX, yet elevated ceramide only to a level equivalent to limited
pro-caspase 8 transfection. Ceramide elevations were detected
concurrently by diacylglycerol kinase and electrospray tandem mass
spectrometry. These investigations provide evidence that
ceramide generation is initiator
caspase-dependent and occurs prior to commitment to
the effector phase of apoptosis, definitively ordering ceramide as
proximal in CD95 signaling.
CD95(Fas/APO-1) Signals Ceramide Generation Independent of
the Effector Stage of Apoptosis*
,
Laboratory of Signal Transduction and
¶ Department of Radiation Oncology, Memorial Sloan-Kettering
Cancer Center, New York, New York 10021 and the § Department
of Biochemistry, Emory University, Atlanta, Georgia 30322
*
This work was supported by Grants CA42385 and CA52462 (to
R. K. and Z. F., respectively) from the National Institutes
of Health, Grant GM46368 (to A. M.), and by a fellowship of
Deutsche Krebshilfe (to C. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of
Signal Transduction, Memorial Sloan-Kettering Cancer Center, 1275 York
Ave., New York, NY 10021. Tel.: 212-639-7558; Fax: 212-639-2767.
This article has been cited by other articles:
![]() |
R. Reinehr, A. Sommerfeld, V. Keitel, S. Grether-Beck, and D. Haussinger Amplification of CD95 Activation by Caspase 8-induced Endosomal Acidification in Rat Hepatocytes J. Biol. Chem., January 25, 2008; 283(4): 2211 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rotolo, J. Zhang, M. Donepudi, H. Lee, Z. Fuks, and R. Kolesnick Caspase-dependent and -independent Activation of Acid Sphingomyelinase Signaling J. Biol. Chem., July 15, 2005; 280(28): 26425 - 26434. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Soderstrom, S. D. Nyberg, and J. E. Eriksson CD95 capping is ROCK-dependent and dispensable for apoptosis J. Cell Sci., May 15, 2005; 118(10): 2211 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lepine, B. Lakatos, M.-P. Courageot, H. Le Stunff, J.-C. Sulpice, and F. Giraud Sphingosine Contributes to Glucocorticoid-Induced Apoptosis of Thymocytes Independently of the Mitochondrial Pathway J. Immunol., September 15, 2004; 173(6): 3783 - 3790. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Frago, S. Canon, E. J. de la Rosa, Y. Leon, and I. Varela-Nieto Programmed cell death in the developing inner ear is balanced by nerve growth factor and insulin-like growth factor I J. Cell Sci., February 1, 2003; 116(3): 475 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erdreich-Epstein, L. B. Tran, N. N. Bowman, H. Wang, M. C. Cabot, D. L. Durden, J. Vlckova, C. P. Reynolds, M. F. Stins, S. Groshen, et al. Ceramide Signaling in Fenretinide-induced Endothelial Cell Apoptosis J. Biol. Chem., December 13, 2002; 277(51): 49531 - 49537. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Pru, I. R. Hendry, J. S. Davis, and B. R. Rueda Soluble Fas Ligand Activates the Sphingomyelin Pathway and Induces Apoptosis in Luteal Steroidogenic Cells Independently of Stress-Activated p38MAPK Endocrinology, November 1, 2002; 143(11): 4350 - 4357. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia-Ruiz, A. Colell, A. Morales, M. Calvo, C. Enrich, and J. C. Fernandez-Checa Trafficking of Ganglioside GD3 to Mitochondria by Tumor Necrosis Factor-alpha J. Biol. Chem., September 20, 2002; 277(39): 36443 - 36448. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Green Apoptosis and Sphingomyelin Hydrolysis: The Flip Side J. Cell Biol., July 11, 2000; 150(1): F5 - F8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kirschnek, F. Paris, M. Weller, H. Grassme, K. Ferlinz, A. Riehle, Z. Fuks, R. Kolesnick, and E. Gulbins CD95-mediated Apoptosis in Vivo Involves Acid Sphingomyelinase J. Biol. Chem., August 25, 2000; 275(35): 27316 - 27323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lozano, S. Menendez, A. Morales, D. Ehleiter, W.-C. Liao, R. Wagman, A. Haimovitz-Friedman, Z. Fuks, and R. Kolesnick Cell Autonomous Apoptosis Defects in Acid Sphingomyelinase Knockout Fibroblasts J. Biol. Chem., January 5, 2001; 276(1): 442 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paris, H. Grassme, A. Cremesti, J. Zager, Y. Fong, A. Haimovitz-Friedman, Z. Fuks, E. Gulbins, and R. Kolesnick Natural Ceramide Reverses Fas Resistance of Acid Sphingomyelinase-/- Hepatocytes J. Biol. Chem., March 9, 2001; 276(11): 8297 - 8305. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-J. Kroesen, B. Pettus, C. Luberto, M. Busman, H. Sietsma, L. de Leij, and Y. A. Hannun Induction of Apoptosis through B-cell Receptor Cross-linking Occurs via de Novo Generated C16-Ceramide and Involves Mitochondria J. Biol. Chem., April 20, 2001; 276(17): 13606 - 13614. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Cottin, A. A. Van Linden, and D. W. H. Riches Phosphorylation of the Tumor Necrosis Factor Receptor CD120a (p55) Recruits Bcl-2 and Protects against Apoptosis J. Biol. Chem., May 11, 2001; 276(20): 17252 - 17260. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cremesti, F. Paris, H. Grassme, N. Holler, J. Tschopp, Z. Fuks, E. Gulbins, and R. Kolesnick Ceramide Enables Fas to Cap and Kill J. Biol. Chem., June 22, 2001; 276(26): 23954 - 23961. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |